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The activity-dependent transcription factor myocyte
enhancer factor 2 (MEF2) induces excitatory synapse
elimination in mouse neurons, which requires fragile
Xmental retardation protein (FMRP), an RNA-binding
protein implicated in human cognitive dysfunction
and autism. We report here that protocadherin 10
(Pcdh10), an autism-spectrum disorders gene, is
necessary for this process. MEF2 and FMRP cooper-
atively regulate the expression of Pcdh10. Upon
MEF2 activation, PSD-95 is ubiquitinated by the
ubiquitin E3 ligase murine double minute 2 (Mdm2)
and then binds to Pcdh10, which links it to the pro-
teasome for degradation. Blockade of the Pcdh10-
proteasome interaction inhibits MEF2-induced
PSD-95 degradation and synapse elimination. In
FMRP-lacking neurons, elevated protein levels of eu-
karyotic translation elongation factor 1 a (EF1a), an
Mdm2-interacting protein and FMRP target mRNA,
sequester Mdm2 and prevent MEF2-induced PSD-
95 ubiquitination and synapse elimination. Together,
our findings reveal roles for multiple autism-linked
genes in activity-dependent synapse elimination.
INTRODUCTION
Sensory experience, learning, and neuronal activity stabilize or
eliminate select excitatory synapses and sculpt the mature
neuronal circuits that mediate sensory processing and memory
(Xu et al., 2009; Yang et al., 2009). The cellular mechanisms
that underlie activity or experience-dependent synapse elimina-
tion in the central nervous system are largely unknown. The
discovery that activation of the myocyte enhancer factor 2
(MEF2) family of transcription factors suppresses synapse
number provides an important molecular link to understandChow neuronal activity leads to synapse elimination (Flavell
et al., 2006; Pfeiffer et al., 2010; Tian et al., 2010). MEF2 is
activated upon neuronal depolarization and calcium influx, which
induces the expression of MEF2 target genes that are thought
to lead to synapse elimination (Flavell et al., 2006, 2008; McKin-
sey et al., 2002; Pulipparacharuvil et al., 2008). The identity of the
MEF2 target genes that promote synapse elimination or their
mechanisms of action in synapse elimination is unknown. We
recently demonstrated that MEF2-induced synapse elimination
requires fragile X mental retardation protein (FMRP) (Pfeiffer
et al., 2010), an RNA-binding protein that regulates translation
of its target mRNAs (Bassell and Warren, 2008). FMRP is en-
coded by the Fmr1 gene, which is transcriptionally silenced in
patients with fragile X syndrome (FXS), the most common
inherited form of intellectual disability and autism (Abrahams
and Geschwind, 2008; Kelleher and Bear, 2008). In neurons of
the mouse model of FXS, Fmr1 knockout (KO), MEF2-triggered
synapse elimination is absent (Pfeiffer et al., 2010), which
may contribute to the observed excess of dendritic spines on
cortical neurons of FXS patients and the Fmr1 KO mouse
(Bagni and Greenough, 2005). The mechanisms that underlie
the deficiencies in synapse elimination associated with FXS are
unknown. Our previous results indicated that FMRP functions
downstream of MEF2-induced transcription to eliminate syn-
apses (Pfeiffer et al., 2010). Based on the known function of
FMRP, we hypothesized that FMRP regulated translation of
MEF2-generated transcripts.
To identify candidate transcripts involved in synapse elimina-
tion, we compared the known MEF2 target genes (Flavell et al.,
2008) with FMRP-interacting mRNAs (Darnell et al., 2011). Of
the many common MEF2- and FMRP-interacting transcripts,
we focused on protocadherin 10 (Pcdh10), also known as
OL-protocadherin, a member of the cadherin superfamily of
calcium-dependent cell adhesion molecules (Morishita and
Yagi, 2007). Importantly, homologous deletion of Pcdh10 in
humans is associated with autism (Morrow et al., 2008).
Pcdh10 and other family members of the d2 nonclustered proto-
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binding activity relative to the classical cadherins (Hirano et al.,
1999). Furthermore, the diverse structure of protocadherins’
cytoplasmic C termini is consistent with the multifunctional roles
of protocadherins in cell signaling and function, in addition to cell
adhesion (Kim et al., 2011; Yasuda et al., 2007). Pcdh10 is
primarily expressed in the brain (Hirano et al., 1999), where it is
required for the growth of striatal axons and patterning of thala-
mocortical and corticothalamic projections during embryonic
development (Uemura et al., 2007). Interestingly, Pcdh10 is
highly expressed in mature cortical neurons, where nothing is
known of its function (Kim et al., 2011).
Here, we demonstrate that Pcdh10 is required for
MEF2-induced synapse elimination and functions to deliver
ubiquitinated postsynaptic density protein 95 (PSD-95), a critical
synaptic scaffolding molecule to the proteasome. Fmr1 KO
neurons have deficits in ubiquitination and degradation of
PSD-95, and we uncover the molecular basis of this defect.
Our results reveal mechanisms by which the activity-dependent
transcription factor MEF2 refines synaptic connections in
wild-type neurons and identify the mechanisms that underlie
abnormal synapse refinement in fragile X syndrome. Importantly,
this work demonstrates the necessity and distinct cellular
functions of three genes linked to autism in the same synapse
elimination process (Pcdh10, Fmr1. and Mef2; Novara et al.,
2010) and thus provides evidence for a common synaptic deficit
among different genetic causes of autism.
RESULTS
MEF2 and FMRP Regulate Pcdh10 Expression
in Dendrites
To study the role of Pcdh10 in MEF2 and FMRP regulation of
synapse number, we first validated the association of FMRP
and Pcdh10 mRNA (Darnell et al., 2011). We performed an
RNA immunoprecipitation with an anti-FMRP antibody and
pulled down Pcdh10 mRNA from hippocampal lysates of wild-
type (WT) mice, but not Fmr1 KO mice (Figure 1A), providing
evidence for Pcdh10 as an mRNA target of FMRP. We next
examined whether Pcdh10 expression is regulated by MEF2
and FMRP, using lentivirus to transfect tamoxifen-inducible,
constitutively active MEF2 (MEF2-VP16ERtm) (Flavell et al.,
2006; Pfeiffer et al., 2010) into dissociated cortical neuron
cultures, which are amenable to biochemical assays. Basal
levels of Pcdh10 mRNA and another MEF2 target gene Nurr77
were not different between WT and Fmr1 KO neurons (vehicle;
white bars, Figure 1B). After 6 hr of 4-hydroxytamoxifen (tamox-
ifen, 1 mm) treatment, which induces translocation of MEF2-
VP16ERtm to the nucleus to activate target genes (Flavell
et al., 2006), both Pcdh10 and Nurr77 mRNAs were elevated in
WT and Fmr1 KO neurons (black bars, Figure 1B), indicating
that FMRP is not required for MEF2-induced transcription of
target genes. Surprisingly, the level of Pcdh10 mRNA induced
with MEF2 activation in Fmr1 KO neurons was greater than in
WT neurons, perhaps reflecting a role of FMRP in RNA stability
(Zhang et al., 2007). In contrast, Pcdh10 protein is basally higher
in Fmr1 KO neurons and is unresponsive toMEF2 activation (Fig-
ure 1C). Similar to cultured neurons, Pcdh10 protein is elevated
in hippocampal lysates of Fmr1 KO mice (Figures 1D and S1A).1582 Cell 151, 1581–1594, December 21, 2012 ª2012 Elsevier Inc.One function of FMRP is to suppress translation of its mRNA
targets (Darnell et al., 2011; Napoli et al., 2008), suggesting
that elevated Pcdh10 in Fmr1 KO neurons is due to increased
translation rate. To test this possibility, we performed metabolic
labeling under basal and MEF2 activated conditions. 35S-Met/
Cys was added with vehicle or tamoxifen for 6 hr to MEF2-
VP16ERtm-transfected cultures followed by immunoprecipita-
tion of Pcdh10 or Tubulin (normalization control). We observed
enhanced newly synthesized Pcdh10 in WT neurons upon
tamoxifen treatment (Figure 1E). In Fmr1 KO neurons, basal
translation rates of Pcdh10 were elevated and MEF2 activation
failed to further increase Pcdh10 synthesis. To determine
whether MEF2 regulates the half-life of Pcdh10, we applied
a 2 hr pulse of 35S-Met/Cys label to neuronal cultures and
chased this with fresh medium containing vehicle or tamoxifen
for the time points indicated in Figure 1F. The half-life of
Pcdh10 was not affected by genotype or MEF2 activation (Fig-
ure 1F). This data indicates that the elevated basal levels of
Pcdh10 in Fmr1 KO neurons are due to elevated protein
synthesis rates and not reduced turnover.
To determine whether dendritic Pcdh10 protein levels are
elevated in Fmr1 KO neurons and to assess the cell autonomous
role of FMRP in regulation of Pcdh10, we performed immunohis-
tochemistry for Pcdh10 and microtubule-associated protein 2
(MAP2), a dendritic marker, in dissociated neuron cultures
prepared from GFP/Fmr1 mosaic mice (i.e., GFP+ cells are
‘‘wild type’’ and GFP cells are Fmr1 KO; see Extended Exper-
imental Procedures available online). Immunohistochemistry
confirmed that FMRP and GFP are coexpressed in hippocampal
and cortical neurons of GFP/Fmr1 mosaic mice (Niere et al.,
2012) (Figure S1B). Pcdh10, but not MAP2, were elevated in
both the soma and dendrites of Fmr1 KO neurons (Figure 1G)
in comparison to neighboring GFP+, WT neurons. These results
support a role for FMRP in translational suppression of Pcdh10,
which leads to elevated Pcdh10 in Fmr1 KO neurons.
Immunohistochemistry for Pcdh10 in WT cultures revealed
that Pcdh10 was present in dendritic spines where PSD-95,
the postsynaptic excitatory synapse marker, was also enriched
(Figure 1H). To validate the specificity of the antibody used for
immunohistochemistry, we performed staining on hippocampal
neurons transfected with two independent shRNAs against
Pcdh10 (Figure S1C). The results showed similar knockdown
efficiency (>50%) by shRNAs as observed with western blot
(Figures 3F and S3B), validating the fluorescence signal of
Pcdh10 seen in Figure 1H. Therefore, Pcdh10 is present in
spines at the site of excitatory synapses and may function in
MEF2 regulation of excitatory synapse number.
Pcdh10 Is Required for MEF2-Induced Synapse
Elimination
Because the expression of Pcdh10 is regulated by both MEF2
and FMRP, we hypothesized that Pcdh10 is required for
MEF2- and FMRP-dependent synapse elimination (Pfeiffer
et al., 2010). We first determined whether manipulation of
Pcdh10 alone was sufficient to affect excitatory synaptic trans-
mission. To do this, we overexpressed mouse Pcdh10 in WT or-
ganotypic hippocampal slice cultures using biolistic transfection
(Figures S2A and S2B) (Pfeiffer et al., 2010). At 16–30 hr after
Figure 1. MEF2 and FMRP Coregulate Pcdh10 Expression
(A) Quantitative real-time RT-PCR of Pcdh10 precipitated with anti-FMRP antibody or IgG from wild-type (WT) or Fmr1 KO mouse brains. Plotted is average of
Pcdh10/Gapdh mRNA. n = 5 mice per genotype.
(B and C) (B) Quantitative real-time RT-PCR of Pcdh10/Gapdh and Nurr77/Gapdh mRNA and (C) Western blots of Pcdh10 from vehicle (V)- or 4-hydrox-
ytamoxifen-treated (tamoxifen or ‘‘T’’) WT or Fmr1 KO cortical neurons transfected with MEF2-VP16ERtm. n = 5 independent cultures for real-time RT-PCR and
n = 3 for western blots.
(D) Western blots of Pcdh10 from WT or Fmr1 KO hippocampi. n = 4 mice per genotype.
(E) 35S-Met/Cys metabolic labeling from vehicle-treated or tamoxifen-treated (T) WT or Fmr1 KO cortical neurons transfected with MEF2-VP16ERtm followed by
immunoprecipitation of Pcdh10 and Tubulin. Plotted is average of Pcdh10/Tubulin. n = 3 cultures.
(F) 35S-Met/Cys pulse-chase assay of Pcdh10 from vehicle- or T-treated WT or Fmr1 KO cortical neurons transfected with MEF2-VP16ERtm. Plotted is average
half-life of Pcdh10. n = 3 cultures.
(G) Immunohistochemistry of GFP with Pcdh10 or MAP2 from hippocampal neurons of GFP/Fmr1mosaic mouse. Selected GFP-positive (WT) and GFP-negative
(Fmr1 KO) areas are enlarged in the middle. Quantification of fluorescence intensity from soma and dendrites is shown on the right. Scale bar, 20 mm. n = 21 cells
for both WT and Fmr1 KO.
(H) Immunohistochemistry of Pcdh10 and PSD-95 from dissociated hippocampal neurons of WT or Fmr1 KO mice.
GFP was used to visualize dendritic spines. Arrows indicate spines. Error bars represent SEM. Scale bar, 5 mm. *p < 0.05, **p < 0.01, ***p < 0.001.
See also Figure S1.transfection, we performed simultaneous whole-cell patch
clamp recordings from Pcdh10-transfected and neighboring un-
transfected CA1 pyramidal neurons. Pcdh10 overexpression
had no effect on excitatory synaptic transmission, as measured
by the frequency or amplitude of miniature (m) EPSCs or evoked
EPSC amplitude (Figure S2B and Table S1). Similarly, there was
no effect of Pcdh10 on paired-pulse facilitation (PPF) of evoked
EPSCs, an indicator of presynaptic release probability (Table
S1). In the converse experiment, we knocked down endogenous
Pcdh10 inWT hippocampal slice cultures using either one of two
shRNAs targeting different regions of Pcdh10 mRNA. After 40–
60 hr transfection, neither shRNA against Pcdh10 nor a control
nontarget shRNA had any effect on the aforementioned
measurements of excitatory synaptic function (Figures S2C,CS2D, and S2E and Table S1). Similarly, transfection of dissoci-
ated hippocampal cultures with either Flag-Pcdh10 or shRNA
against Pcdh10 (Figures S2F and S2G) had no effect on synapse
number, asmeasured by coclusters of the pre- and postsynaptic
proteins synapsin-1 and PSD-95, or PSD-95 puncta number and
size. These results indicate that acute changes in Pcdh10 levels
are not sufficient to affect excitatory synaptic function.
To test whether Pcdh10 is required for MEF2-induced
synapse elimination, we cotransfected WT hippocampal slice
cultures with plasmids generating either one of two shRNAs
against Pcdh10 together with MEF2-VP16ERtm. Sister cultures
were cotransfected with a control shRNA together with MEF2-
VP16ERtm. After 24 hr, tamoxifen was applied to the slices to
activate MEF2 for another 16–32 hr, followed by simultaneousell 151, 1581–1594, December 21, 2012 ª2012 Elsevier Inc. 1583
Figure 2. Pcdh10 Is Required for MEF2-Induced Functional Synapse Elimination in WT Neurons
(A) Average evoked EPSC amplitude (A1) and mEPSC frequency (A2) from untransfected and control shRNA with MEF2-VP16ERtm-transfected CA1 neurons in
slice culture. n = 13 for both A1 and A2.
(B) Average evoked EPSC amplitude (B1) and mEPSC frequency (B2) from untransfected and Pcdh10 shRNA with MEF2-VP16ERtm-transfected cells. n = 16 for
both B1 and B2.
(C) Average evoked EPSC amplitude (C1) and mEPSC frequency (C2) from untransfected and Pcdh10 shRNA with MEF2-VP16ERtm and shRNA-insensitive
Pcdh10 construct-transfected cells. n = 24 for both C1 and C2.
Error bars represent SEM. *p < 0.05. Representative evoked EPSC andmEPSC traces are shown with the dot plots of individual cell pairs and on the right of each
figure, respectively. See also Figure S2 and Table S1.recordings of transfected and neighboring untransfected CA1
neurons. As shown, neurons transfected with MEF2-VP16ERtm
and control shRNA had a decrease in mEPSC frequency and
evoked EPSC amplitude but no change in PPF (Figure 2A
and Table S1). These changes are consistent and correlate
with structural synapse elimination that we previously demon-
strated with MEF2-VP16ERtm in this preparation (Flavell et al.,
2006; Pfeiffer et al., 2010). However, MEF2-induced functional
synapse elimination was blocked in neurons transfected with
shRNA against Pcdh10 (Figures 2B and S2H and Table S1)
and rescued by cotransfection of a shRNA-insensitive Pcdh10
(Figure 2C and Table S1) together with the Pcdh10 shRNA.1584 Cell 151, 1581–1594, December 21, 2012 ª2012 Elsevier Inc.shRNA-mediated knockdown of Pcdh10 did not affect
MEF2-induced transcription of Nurr77 as measured with
real-time RT-PCR (Figure S2I), suggesting that Pcdh10 func-
tions in synapse elimination downstream of MEF2 activated
transcription.
MEF2 Induces Pcdh10-Dependent Degradation
of PSD-95
To determine the cellular mechanism by which Pcdh10mediates
MEF2-induced synapse elimination, we turned to dissociated
cortical neuron cultures, which are amenable to biochemical
methods. We hypothesized that MEF2 activation causes rapid
Figure 3. MEF2 Induces Pcdh10-Dependent Degradation of PSD-95
(A) Western blots of postsynaptic proteins from dissociated WT or Fmr1 KO cortical neurons transfected with MEF2-VP16ERtm and treated with either vehicle or
tamoxifen for 6 hr. Quantification of PSD-95 is shown on the right. n = 3 cultures.
(B) Immunohistochemistry of PSD-95 from dissociated WT or Fmr1 KO hippocampal neurons transfected with MEF2-VP16ERtm and treated with either vehicle
or tamoxifen for 6 hr. Bicistronic GFP from MEF2-VP16ERtm plasmid and endogenous MAP2 serve as transfection control and quantification control,
respectively. Scale bars, 5 mm. Quantifications of total PSD-95 intensity, PSD-95 puncta number, PSD-95 puncta size, and GFP intensity are shown on the right.
n = 21 cells/condition.
(C) 35S-Met/Cys metabolic labeling from vehicle- or tamoxifen-treated WT or Fmr1 KO cortical neurons transfected with MEF2-VP16ERtm followed by immu-
noprecipitation of PSD-95 and Tubulin. Plotted is average of Pcdh10/Tubulin. n = 3 cultures.
(D) 35S-Met/Cys pulse-chase assay of Pcdh10 from vehicle- or tamoxifen-treated WT or Fmr1 KO cortical neurons transfected with MEF2-VP16ERtm. Plotted is
the average half-life of Pcdh10. n = 3 cultures.
(E)Western blots of PSD-95 and Tubulin from dissociatedWT or Fmr1KO cortical neurons transfectedwithMEF2-VP16ERtm and treatedwith vehicle, tamoxifen,
and/or proteasome inhibitor MG132, as indicated for 6 hr. Quantification is shown below. n = 4 cultures.
(F) Western blots of PSD-95, Pcdh10, and Tubulin from dissociated cortical neurons of WT or Fmr1 KO mice transfected with MEF2-VP16ERtm and Pcdh10
shRNA. Quantification is shown below. n = 3 cultures.
Error bars represent SEM. **p < 0.01. See also Figure S3.synapse elimination by the regulated degradation of synaptic
scaffolding proteins. To investigate this possibility, wemonitored
the level of several postsynaptic scaffolding proteins in MEF2-
VP16ERtm transfected cortical neuron cultures after 6 hr of
tamoxifen treatment. As shown in Figure 3A, PSD-95 levels
were significantly decreased in WT neurons, whereas other
synaptic proteins (mGluR5, Homer, and CaMKIIa) remained
unchanged. Consistent with the deficit in MEF2-induced
synapse elimination in Fmr1 KO neurons, PSD-95 levels were
unchanged upon MEF2 activation in Fmr1 KO neurons. Similar
results were observed with immunohistochemistry for PSD-95Cin dissociated hippocampal neurons (Figure 3B). This result
also suggests that the downregulation of PSD-95 is a common
consequence of MEF2 activation in both cortical and hippo-
campal neurons.
To determine whether the downregulation of PSD-95 resulted
from reduced synthesis or increased degradation, we performed
metabolic labeling with 35S-Met/Cys in dissociated cortical
neuron cultures. After 6 hr of MEF2 activation and 35S-Met/Cys
label, there was no change in newly synthesized PSD-95 from
either WT or Fmr1 KO neurons (Figure 3C). However, using
the pulse-chase 35S-Met/Cys labeling assay, the half-life ofell 151, 1581–1594, December 21, 2012 ª2012 Elsevier Inc. 1585
(legend continued on next page)
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PSD-95 was reduced by 35% after MEF2 activation in WT
neurons (Figure 3D). Like PSD-95 protein levels (Figures 3A
and 3B), PSD-95 half-life was unaffected by MEF2 activation in
Fmr1 KO neurons. To investigate whether MEF2-induced degra-
dation of PSD-95 in WT neurons is proteasome dependent, we
applied proteasome inhibitors MG132 (5 mM) or lactacystin
(5 mM), together with tamoxifen (Figures 3E and S3A). Both
MG132 and lactacystin blocked MEF2-induced downregulation
of PSD-95 in WT neurons, and no changes in PSD-95 were
observed under any condition in Fmr1 KO neurons.
To determine whether MEF2-induced degradation of PSD-95
is mediated by Pcdh10, we used lentivirus to deliver MEF2-
VP16ERtm along with one of two different shRNAs against
Pcdh10 into dissociated cortical neuron cultures. Knocking
down Pcdh10 with either shRNA inhibited MEF2-induced
PSD-95 degradation (Figures 3F and S3B). PSD-95 degradation
is rescued by lentiviral coexpression of shRNA-insensitive
Pcdh10 together with the Pcdh10 shRNA (Figure S3C). These
findings indicate that Pcdh10 is required for MEF2-induced
degradation of PSD-95 and suggest a molecular mechanism
for Pcdh10 in MEF2-induced synapse elimination.
Pcdh10 Facilitates the Proteasomal Deposition
of Ubiquitinated PSD-95
To better determine the role of Pcdh10 in MEF2-induced regula-
tion of PSD-95, we investigated whether Pcdh10 physically
associated with PSD-95 and whether this changed with MEF2
activation. Using coimmunoprecipitation of Pcdh10 with PSD-
95 from cortical neuron cultures (in the presence of MG132),
we found that Pcdh10 could associate with PSD-95 (Figure 4A).
Activation of MEF2 for 6 hr drastically increased the association
between Pcdh10 and PSD-95 inWT neurons, but not in Fmr1 KO
neurons (Figure 4A). Similar results were obtained in hippo-
campal neuron cultures (Figure S4A). Given that MEF2 increases
the expression of Pcdh10 in WT cultures (Figure 1D), we consid-
ered whether the MEF2-induced association of Pcdh10 and
PSD-95 is due to enhanced production of Pcdh10. We used
lentivirus to transfect WT or Fmr1 KO cortical cultures with
a Flag-tagged Pcdh10 driven by the cytomegalovirus (CMV)
promoter whose transcription is not regulated by MEF2.
Although total Flag-Pcdh10 levels were unchanged upon MEF2
activation, immunoprecipitation of PSD-95 revealed an increase
in Flag-Pcdh10 association with PSD-95 (Figure 4B, in the pres-Figure 4. Pcdh10 Facilitates the Proteasomal Degradation of Ubiquitin
(A and B) Western blots of (A) endogenous Pcdh10 or (B) Flag-Pcdh10 coimmuno
WT or Fmr1 KO cortical neurons transfected with (A) MEF2-VP16ERtm or (B) MEF
6 hr. Inputs and quantification results are shown on the bottom and on the right.
(C) Western blots of ubiquitin after immunoprecipitation of PSD-95 (top). Weste
panels from the top). Western blots of PSD-95 and Rpt1 after pull-down with
dissociated WT or Fmr1 KO cortical neurons transfected with MEF2-VP16ERtm
inputs are shown on the bottom.
(D) Western blots of Pcdh10 fromWT brain lysates pulled down by increasing amo
used for the assay was detected by anti-PSD-95 antibody shown in the middle
shown on the bottom. Arrowhead and arrows indicate native and ubiquitinated P
(E) Western blots of Pcdh10, Rpt1, CaMKIIa, Pcdh9, and Tubulin fromWT or Fmr1
are shown on the bottom after Coomassie blue staining on a SDS-PAGE gel.
(F) Western blots of GST or GST-Pcdh10-C terminus pulled down by purified pro
Experiments in (A), (B), and (C) were done in the presence of MG132. Error bars
Cence of MG132). This suggests that MEF2 promotes the associ-
ation of Pcdh10 with PSD-95 independent of regulating Pcdh10
levels. In Fmr1 KO cultures, MEF2 activation did not stimulate an
interaction of PSD-95 with Flag-Pcdh10, suggesting that the
deficit in PSD95 degradation in Fmr1 KO neurons is not due to
the lack of MEF2-triggered Pcdh10 translation but instead on
a distinct function of FMRP.
To determine the mechanism by which Pcdh10 regulates
MEF2-dependent PSD-95 proteasomal degradation, we exam-
ined ubiquitination of PSD-95. MEF2 activation in WT cultures
resulted in PSD-95 ubiquitination, as observed by immunopre-
cipitation of PSD-95 followed by western blotting with an anti-
ubiquitin (Ub) antibody (in the presence of MG132, Figure 4C,
top). Similar to previous reports (Colledge et al., 2003; Rezvani
et al., 2007), polyubiquitinated PSD-95 was observed as
multiple, distinct high-molecular-weight bands (115–200 kDa).
Knockdown of Pcdh10 with a lentiviral-expressed shRNA had
a slight effect on MEF2-induced PSD-95 ubiquitination.
However, using GST-Ubl (ubiquitin-like domain from Rad23)
(Bingol et al., 2010) to pull down the proteasome and protea-
some-interacting proteins (in the presence of MG132), we could
only detect ubiquitinated PSD-95 in neurons transfected with
MEF2 plus control shRNA, but not Pcdh10 shRNA (Figure 4C,
second panel from the top, and S4B). These results suggest
that the predominant role of Pcdh10 is to associate ubiquitinated
PSD-95 with the proteasome.
Because Pcdh10 is important for association of ubiquitinated
PSD-95 with the proteasome, we next asked whether PSD-95
ubiquitination or proteasome association is deficient in Fmr1
KO neurons. In contrast to WT cultures, MEF2 activation in
Fmr1 KO cultures failed to increase PSD-95 ubiquitination (Fig-
ure 4C). Consistent with these results, basal ubiquitination of
PSD-95 is reduced in vivo in Fmr1 KO hippocampi (Figure S4C).
Taken together, these findings suggest that FMRP and Pcdh10
have distinct roles in MEF2-induced PSD-95 degradation: (1)
FMRP is required for MEF2-induced ubiquitination of PSD-95,
and (2) Pcdh10 is primarily required for linking ubiquitinated
PSD-95 to the proteasomal machinery.
Based on results in WT cultures, we hypothesize that Pcdh10
associates ubiquitinated PSD-95 with the proteasome. To test
this idea, we determined whether Pcdh10 interacts with ubiqui-
tinated PSD-95 in vitro. We prepared native and ubiquitinated
GST-PSD-95 by in vitro ubiquitination and observed thatated PSD-95
precipitated by anti-PSD-95 antibody. Protein samples were from dissociated
2-VP16ERtm plus Flag-Pcdh10 and treated with either vehicle or tamoxifen for
n = 4 cultures.
rn blots of PSD-95 and Rpt1 after pull-down with GST-Ubl (second and third
GST alone (fourth and fifth panels from the top). Protein samples were from
with either control shRNA or Pcdh10 shRNA. Treatment is as indicated, and
unt of native GST-PSD-95 or in vitro ubiquitinated GST-PSD-95. GST-PSD-95
panel, whereas ubiquitinated GST-PSD-95 was detected by anti-HA antibody
SD-95, respectively.
KOmice brains after pull-down with either GST or GST-Ubl. GST proteins used
teasome from Flag-Rpt6 stably expressing HEK293 cells.
represent SEM. **p < 0.01. See also Figure S4.
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Pcdh10 from WT brain lysates preferentially interacts with ubiq-
uitinated, but not native, GST-PSD-95 (Figure 4D). Ubiquitinated
GST-PSD-95 failed to interact with in-vitro-translated Pcdh10
(Figure S4D), suggesting that posttranslational modifications of
Pcdh10 or other interacting proteins are necessary. To test
whether Pcdh10 interacts with the proteasome, we used
GST-Ubl to pull down the proteasome and find that Pcdh10,
the proteasome component Rpt1 (Demartino and Gillette,
2007), and the proteasome-interacting protein CaMKIIa (Bingol
et al., 2010) were pulled down from both WT and Fmr1 KO
mouse brain (Figure 4E). In contrast, another protocadherin-
d family member, Pcdh9 (Morishita and Yagi, 2007), was not
pulled down by GST-Ubl. The interaction of Pcdh10 and the
proteasome was also confirmed by the demonstration that the
GST-tagged C terminus of Pcdh10 interacts with a purified pro-
teasome preparation from Flag-Rpt6 stably expressing HEK293
cells (Kim and DeMartino, 2011) (Figures 4F and S4E). Together,
these results suggest that Pcdh10 interacts with ubiquitinated
PSD-95 and the proteasome, and this interaction may not be
conserved in other protocadherin family members.
We next determined whether MEF2-induced PSD-95 degra-
dation and synapse elimination required Pcdh10 association
with the proteasome. Toward this goal, we first mapped the
minimum region of Pcdh10 that is required for interaction with
the proteasome. We focused on the C terminus of Pcdh10
(266 amino acid) because it is predicted to be a cytoplasmic
domain (Morishita and Yagi, 2007). We made various deletion
constructs of the C terminus of Pcdh10 tagged with GST and
tested their ability to pull down proteasomal complexes from
brain lysates, as determined by association with the essential
proteasome protein component Rpt1 (Bingol et al., 2010) (Fig-
ure 5A). Using this assay, we identified a 102 amino acid region
(amino acids 778–879) of Pcdh10 required for the interaction
with the proteasome. Amino acids 778–879 are highly conserved
in Pcdh10 across species (Figure S5A), and we termed this
sequence the proteasome interacting region (PIR).
We aimed to determine whether Pcdh10 association with the
proteasome is necessary for MEF2-induced PSD-95 degrada-
tion and synapse elimination. In preparation for these experi-
ments, we expressed a Flag-tagged PIR in WT cultured neurons
and found that it distributes in dendrites and spines but did not
alter general proteasome activity (Figures S5B and S5C). Impor-
tantly, Flag-PIR expression effectively competed with Pcdh10
and greatly reduced the association of endogenous Pcdh10
with the proteasome in neurons, as assessed by GST-Ubl
pull-down (Figure 5B). Coexpression of Flag-PIR and MEF2-
VP16ERtm in WT cortical neuron cultures blocked MEF2-
induced degradation of PSD-95 (Figure 5C). Similarly, biolistic
cotransfection of Flag-PIR and MEF2-VP16 into CA1 neurons
ofWTmouse hippocampal slice cultures blockedMEF2-induced
functional synapse elimination (Figures 5D and 5E and Table S1)
and MEF2-induced reduction in dendritic spine density (Fig-
ure 5F). Expression of Flag-PIR alone did not alter synaptic func-
tion (Figure S5D), spine density (Figure 5F), or MEF2-induced
transcription (Figure S2I). These data demonstrate that Pcdh10
association with the proteasome is necessary for MEF2-induced
PSD-95 degradation, as well as functional and structural
synapse elimination. And based on these and our biochemical1588 Cell 151, 1581–1594, December 21, 2012 ª2012 Elsevier Inc.data (Figure 4), we propose that one role of Pcdh10 in synapse
elimination is to deliver ubiquitinated PSD-95 to the proteasome
for degradation.
The Ubiquitin E3 Ligase for PSD-95, Mdm2,
Is Dysregulated in Fmr1 KO Neurons
In Fmr1 KO neurons, MEF2-induced ubiquitination of PSD-95 is
absent; a process that is independent of Pcdh10. To investigate
the deficit in PSD-95 ubiquitination in Fmr1 KO neurons, we
examined the substrate-specific step of the ubiquitination
process, which involves the ubiquitin E3 ligase for PSD-95,
murine double minute 2 (Mdm2) (Colledge et al., 2003). Using
shRNAs against Mdm2, we observed that Mdm2 is required for
MEF2-induced PSD-95 ubiquitination (Figure 6A) and degrada-
tion (Figures 6B, S6A, S6B, and S6C) in WT cortical neurons,
thus confirming that Mdm2 is the relevant E3 ligase for PSD-
95. To investigate whether Mdm2 is dysregulated in Fmr1 KO
neurons, we performed coimmunoprecipitation and observed
reduced interaction of Mdm2 and PSD-95 in Fmr1 KO hippo-
campus in contrast to WT hippocampus (Figure 6C). Using
immunohistochemistry for Mdm2 in dissociated hippocampal
neurons, we also observed lower colocalization of Mdm2 with
PSD-95 in dendrites of Fmr1 KO neurons compared to WT
neurons (Figure 6D). Although total Mdm2 levels were normal
in Fmr1 KO hippocampus (Figure 6C), Mdm2 levels in synapto-
neurosome fractions of Fmr1 KO hippocampi were reduced to
about 40% of WT levels (Figure 6E). We hypothesized that
MEF2 may enhance the synaptic localization of Mdm2, and
this may be deficient in Fmr1 KO neurons. To test this possibility,
we activated MEF2 in dissociated cortical neuron cultures and
examined Mdm2 levels in synaptoneurosome fractions and in
coimmunoprecipitates with PSD-95. In WT neurons, MEF2
activation increased Mdm2 levels in synaptoneurosomes (Fig-
ure 6F), as well as the interaction between PSD-95 and Mdm2
(Figure 6G). In contrast, in Fmr1 KO neurons, MEF2 failed to
increase Mdm2 levels in synaptoneurosomes or the association
of Mdm2 with PSD-95. MEF2 activation did not alter total Mdm2
levels in either WT or Fmr1 KO cultures (Figures 6B and 6F).
Together, these results indicate that MEF2 stimulates the local-
ization of Mdm2 to the synaptic compartment and to PSD-95,
and this process is defective in Fmr1 KO neurons.
Elevated EF1a Inhibits Mdm2 from Interacting
with PSD-95 in Fmr1 KO Neurons
In Fmr1 KO neurons, Mdm2 localization at the synapse is
reduced, andMEF2-induced redistribution ofMdm2 to synapses
is deficient (Figure 6). We hypothesized that Mdm2 may have an
abnormal interactome in Fmr1 KO neurons. A previous proteo-
mic study to identify human Mdm2 (Hdm2)-interacting proteins
discovered a robust interaction of eukaryotic translation elonga-
tion factor 1-a (EF1a) and Hdm2 (Frum et al., 2007). EF1a is an
FMRP target mRNA, and EF1a protein levels are upregulated
in Fmr1 KO brain (Darnell et al., 2011; Sung et al., 2003). We
hypothesized that elevated EF1a in Fmr1 KO neurons seques-
ters Mdm2 and prevents it from ubiquitinating PSD-95. In
support of this hypothesis, immunoprecipitation of Mdm2 from
hippocampal lysates revealed an increased interaction of EF1a
and Mdm2 in vivo in Fmr1 KO mice (Figure 7A). This increased
Figure 5. Blocking Interaction of Pcdh10 and Proteasome Inhibits MEF2-Induced PSD-95 Degradation and Synapse Elimination
(A)Western blots of Rpt1 fromWTmouse brain after pull-down byGST alone or different GST-Pcdh10 carboxyl terminus proteins. Schematic diagram of Pcdh10-
C-terminal deletions are shown on top. GST proteins used are shown on the right with Coomassie blue staining on a SDS-PAGE gel.
(B) Western blots of Pcdh10, Rpt1, and Flag from dissociatedWT cortical neurons transfected with Flag-PIR after pull-down with either GST or GST-Ubl. Input of
each protein and quantification are shown on the bottom and right, respectively. n = 3 cultures.
(C) Western blots of PSD-95, Flag, and Tubulin from dissociated WT cortical neurons transfected with MEF2-VP16ERtm and Flag-PIR with vehicle or tamoxifen
treatment as indicated. Quantification of PSD-95 level is shown on the right. n = 4 cultures.
(D and E) Average evoked EPSC amplitude (D1) and mEPSC frequency (D2) from untransfected and control vector plus MEF2-VP16-transfected cells. n = 14 for
both D1 and D2. (E) Average evoked EPSC amplitude (E1) and mEPSC frequency (E2) from untransfected and PIR plus MEF2-VP16-transfected cells. n = 16 for
both E1 and E2. Representative evoked EPSC and mEPSC traces are shown with the dot plots and on the right of each figure, respectively.
(F) Quantification and representative images of apical secondary dendrites from WT CA1 pyramidal neurons transfected with GFP plus other plasmids as
indicated. n = 10–20 cells in each condition. Scale bar, 5 mm.
Error bars represent SEM. *p < 0.05, ***p < 0.001. See also Figure S5 and Table S1.interaction may be due to the observed increase in total EF1a
protein in Fmr1 KO (Figure 7A). To determine whether EF1a
and PSD-95 directly compete for interactions with Mdm2, we
obtained recombinant His-Mdm2, GST-EF1a, and GST-PSD-
95. To Ni beadswith boundHis-Mdm2, we first added increasing
amounts of GST-EF1a. After washing off unbound GST-EF1a,
we incubated the complex with GST-PSD-95. Because
a possible degraded product of His-Mdm2 runs at the same
position of GST- EF1a on a SDS-PAGE, we used western blot-Cting to detect the composition of the complex. As shown (Fig-
ure 7B), the binding ofMdm2 to EF1a occurswith a stoichiometry
of 1:1, and EF1a-bound Mdm2 lost the ability to bind PSD-95.
His-Mdm2 also runs at a position approximately doubled to its
predicted molecular weight, suggesting formation of homodimer
(Dolezelova et al., 2012). The GST tag does not interact with His-
Mdm2 nor interfere with the binding of His-Mdm2 to GST-EF1a
or GST-PSD-95 (Figure S7A). To test the affinity of Mdm2 toward
binding EF1a or PSD-95, we premixed GST- EF1a (1 pmol) andell 151, 1581–1594, December 21, 2012 ª2012 Elsevier Inc. 1589
Figure 6. Mdm2 and Mdm2-Mediated Degradation of PSD-95 Are Dysregulated in Fmr1 KO Neurons
(A) Western blots of ubiquitin after immunoprecipitation with PSD-95 (top) or IgG (second panel from the top). Protein samples were from dissociated WT or
Fmr1 KO cortical neurons transfected with either control shRNA or Mdm2 shRNA together with MEF2-VP16ERtm. Treatment was as indicated, and input was
shown on the bottom.
(B) Western blots of PSD-95, Mdm2, and Tubulin from dissociated WT or Fmr1 KO cortical neurons transfected with either control shRNA or Mdm2 shRNA
together with MEF2-VP16ERtm. Quantification is shown on the right. n = 3 cultures.
(C) Western blots of Mdm2 immunoprecipitated with PSD-95 from WT or Fmr1 KO hippocampi. n = 4 mice per genotype.
(D) Immunohistochemistry of dendritic Mdm2 with PSD-95 from dissociated WT or Fmr1 KO hippocampal neurons. Colocalization images are shown on the
bottom. Scale bars, 5 mm. Quantification of colocalization is shown on the right. n = 21 cells.
(E) Western blots of Mdm2, PSD-95, GluR1 (GluA1), and Tubulin in synaptoneurosomes prepared from WT or Fmr1 KO hippocampi. Quantification of Mdm2 in
supernatant or synaptoneurosome is shown on the right. n = 4 mice per genotype.
(F) Western blots of Mdm2, PSD-95, GluR1 (GluA1), and Tubulin after synaptoneurosome preparation of dissociatedWT or Fmr1 KO cortical neurons transfected
with MEF2-VP16ERTm. Quantification of Mdm2 in synaptoneurosome is shown on the right. n = 3 cultures.
(G)Western blots ofMdm2 immunoprecipitated with PSD-95 from dissociatedWT or Fmr1KOcortical neurons transfected withMEF2-VP16ERtm. Quantification
is shown on the right. n = 3 cultures.
Error bars represent SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Experiments in (A), (F), and (G) were done in the presence of MG132. See also Figure S6.GST-PSD-95 (1 pmol), followed by adding Ni beads with bound
His-Mdm2 (0.5 pmol). As shown in Figure 7C, Mdm2 has higher
affinity toward binding EF1a over PSD-95. Together, these
results indicate that EF1a can effectively compete with PSD-95
for binding to Mdm2.
Wehypothesized that reducingEF1a levels inFmr1KOneurons
may release Mdm2, allow interactions with PSD-95, and rescue
MEF2-induced PSD-95 degradation. To test this possibility, we
applied a lentivirus expressing a shRNA against EF1a that
reduced EF1a in Fmr1 KO neurons toWT levels but did not affect
Pcdh10 protein levels (Figure S7B). Knocking down EF1a in Fmr1
KO neurons did not affect MEF2 activation (Figure S7C) but
restoredMEF2-inducedsynaptic localizationofMdm2(Figure7D)
and the interaction between Mdm2 and PSD-95 (Figure 7E).1590 Cell 151, 1581–1594, December 21, 2012 ª2012 Elsevier Inc.Knocking down EF1a also restored MEF2-induced PSD-95
degradation in Fmr1 KO neurons, which required Mdm2 (Fig-
ures 7F and S7D). Coexpression of a shRNA-insensitive EF1a
together with the EF1a shRNA inhibited MEF2-induced synaptic
accumulation of Mdm2 (Figure S7E), the interaction between
PSD-95 and Mdm2 (Figure S7F), and PSD-95 degradation (Fig-
ure S7G) in Fmr1 KO neurons, demonstrating the specificity of
the EF1a shRNA. These results demonstrate that elevated EF1a
in Fmr1 KO neurons inhibits Mdm2 from interacting with PSD-
95 and blocks the subsequent degradation of PSD-95.
To determine whether knocking down EF1a in Fmr1 KO
neurons could also restore MEF2-induced synapse elimination,
we biolistically transfected Fmr1 KO hippocampal slice cultures
with a plasmid encoding a shRNA for EF1a or a control shRNA.
Expression of either shRNA alone had no effect on synaptic
function (Figures S7H and S7I and Table S1). We then cotrans-
fected Fmr1 KO slice cultures with either control shRNA or
EF1a shRNA together with MEF2-VP16ERtm and subsequently
treated the cultures with tamoxifen. Fmr1 KO neurons trans-
fected with control shRNA had a deficit in MEF2-induced func-
tional synapse elimination (Figure 7G), consistent with our
previous report (Pfeiffer et al., 2010). As observed with PSD-95
degradation, EF1a shRNA transfection rescued robust func-
tional synapse elimination in response to MEF2 activation (Fig-
ure 7H). Again, coexpression of a shRNA-insensitive EF1a
together with the EF1a shRNAblockedMEF2-induced functional
synapse elimination (Figure 7I). The shRNA-insensitive EF1a on
its own did not affect excitatory synaptic function (Figure S7J).
Taken together, our results indicate that elevated EF1a in Fmr1
KO neurons inhibits Mdm2 from triggering PSD-95 degradation
and subsequent synapse elimination by MEF2 in the Fmr1 KO
neurons. By knocking down EF1a, we were able to rescue the
following in response to MEF2 activation: (1) synaptic redistribu-
tion of Mdm2, (2) the interaction between Mdm2 and PSD-95, (3)
PSD-95 degradation, and (4) synapse elimination.
DISCUSSION
MEF2 Triggers Synapse Elimination by Promoting
Pcdh10-Dependent Degradation of a Synaptic
Scaffolding Protein
Herewe identified amechanism bywhich the activity-dependent
transcription factor, MEF2, promotes synapse elimination aswell
as the molecular basis of the deficit in synapse elimination
observed in fragile X syndrome, a prevalent cognitive and autistic
disorder. In wild-type neurons, MEF2 activation induces tran-
scription of Pcdh10, which mediates degradation of the synaptic
scaffold PSD-95, and synapse elimination by associating ubiqui-
tinated PSD-95 with the proteasome (Figure 7J). Although trans-
lation of Pcdh10, an FMRP target mRNA, is dysregulated in Fmr1
KO neurons, we find a deficit in MEF2-stimulated ubiquitination
of PSD-95, a step that is upstream and independent of
Pcdh10. The deficit in PSD-95 ubiquitination in Fmr1KO neurons
is caused by elevated levels of EF1a protein, an FMRP target
mRNA, which sequesters Mdm2 from the synapse and PSD-95
(Figure 7J). In support of this conclusion, knockdown of EF1a
levels rescues MEF2-induced PSD-95 degradation and synapse
elimination in Fmr1 KO neurons. Whether MEF2 regulates the
interaction of EF1a and Mdm2 to regulate PSD-95 degradation
in WT neurons is unknown.
Protocadherins and Synapse Elimination
The protocadherins are ancestors of the classical cadherins, the
more well-knownmembers of the Ca2+-dependent cell adhesion
molecule family (Giagtzoglou et al., 2009). Although the
extracellular domains of protocadherins share homology with
the traditional cadherins, they lack a hydrophobic pocket within
extracellular domain 1 that is important for strong homophilic
adhesion (Morishita et al., 2006; Morishita and Yagi, 2007).
Consistent with this prediction, Pcdh10, when expressed in
cell lines, clusters at points of cell contact and stimulates cell
aggregation but less robustly than classical cadherins (HiranoCet al., 1999). A recent study demonstrated that another d2
nonclustered protocadherin family member, Pcdh8 or Arcadlin,
is induced in neurons in response to seizures and interacts in
cis with N-cadherin (a classical cadherin) in postsynaptic mem-
branes. Homophilic interactions of Pcdh8, in cis or trans, recruit
p38 MAPK to its C terminus, which in turn, stimulates the coen-
docytosis of Pcdh8 and N-cadherin and decreases dendritic
spine density (Yasuda et al., 2007). An interesting possibility
is that the induction of the d2 Pcdhs, such as Pcdh8 and
Pcdh10, functions to increase the membrane concentration
and probability of homophilic Pcdh interactions, which activates
key signaling pathways and their endocytosis. Such endocytosis
could facilitate interactions of Pcdh10 with ubiquitinated PSD-95
and the proteasome.
MEF2 Promotes Degradation of a Postsynaptic Scaffold
to Eliminate Synapses
MEF2 activation is associated with a rapid reduction of synapse
number, suggesting that MEF2 eliminates pre-existing synapses
(Flavell et al., 2006; Pfeiffer et al., 2010). However, MEF2 may
also inhibit synapse formation rates. In support of an elimination
mechanism, MEF2 activation caused a rapid and selective
degradation of PSD-95 and a decrease in functional synapse
number—effects that both required the MEF2 transcript,
Pcdh10. Disrupting the association of Pcdh10 with the protea-
some using the PIR peptide blocked MEF2-induced PSD-95
degradation, as well as functional and structural synapse elimi-
nation, suggesting that ubiquitination and Pcdh10-dependent
degradation of PSD-95 are key steps that couple MEF2-driven
transcription to synapse elimination. PSD-95 stabilizes synaptic
AMPARs, increases synaptic function, and results in larger and
more stable spines (Keith and El-Husseini, 2008; Opazo et al.,
2011). Conversely, reductions in PSD-95 can lead to diffusion
and endocytosis of synaptic AMPARs, weaker synapses, smaller
spines, and spine elimination (Colledge et al., 2003; Haas et al.,
2007; Keith and El-Husseini, 2008; Opazo et al., 2011; Woods
et al., 2011). Specifically, in response to NMDAR activation,
PSD-95 is ubiquitinated byMdm2, degraded by the proteasome,
removed from spines, and required for endocytosis of AMPARs
(Colledge et al., 2003; Sturgill et al., 2009). Therefore, MEF2-
triggered degradation of PSD-95 may cause destabilization
and removal of synaptic AMPARs that precedes elimination of
the structural synapse. Of note, knockdown of Pcdh10 pre-
vented MEF2-induced functional synapse elimination, but not
ubiquitination of PSD-95. This suggests that ubiquitination of
PSD-95 is not sufficient to mediate functional synapse elimina-
tion, as Pcdh10-dependent targeting of ubiquitinated PSD-95
to the proteasome is also required.
Recapitulating Synapse Elimination in Fragile
X Syndrome
Fragile X syndrome patients and Fmr1 KO mice display elevated
dendritic spine number in mature cortical neurons, which may
contribute to the neuronal hyperexcitability, sensory hypersensi-
tivity, and epileptic seizures observed in patients and the mouse
model (Berry-Kravis, 2002; Do¨len et al., 2010). A deficit in activity
and MEF2-dependent synapse elimination could lead to excess
spines. In support of this idea, experience-dependent spineell 151, 1581–1594, December 21, 2012 ª2012 Elsevier Inc. 1591
Figure 7. Elevated EF1a in Fmr1 KO Neurons Inhibits Mdm2 from Interacting with PSD-95 and Subsequent PSD-95 Degradation
(A) Western blots of EF1a from WT or Fmr1 KO hippocampi after immunoprecipitation by anti-Mdm2 antibody or IgG. Quantifications on total and immuno-
precipitated EF1a with Mdm2 are shown on the right. n = 3 mice per genotype.
(B)Western blots ofMdm2, EF1a, and PSD-95 after in vitro sequential binding with recombinant proteins. Quantifications of binding and competition are shown in
the middle (n = 3), whereas the purity of recombinant proteins is shown on the right with Coomassie-blue-stained SDS-PAGE gel.
(C) Western blots of GST- EF1a and GST-PSD-95 after in vitro binding with His-Mdm2. Quantification of relative amount of GST proteins pulled down by
His-Mdm2 is on the right. n = 4.
(D) Western blots of Mdm2, PSD-95, EF1a, GluR1 (GluA1), and Tubulin after synaptoneurosome preparation of dissociated Fmr1 KO cortical neurons
transfected with MEF2-VP16ERtm and either control shRNA or EF1a shRNA. Quantification of Mdm2 in synaptoneurosome is shown on the right. n = 3
cultures.
(E) Western blots of Mdm2 immunoprecipitated with PSD-95 from dissociated Fmr1 KO cortical neurons transfected with MEF2-VP16ERtm and either control
shRNA or EF1a shRNA. Quantification is shown on the right. n = 3 cultures. Experiments in (D) and (E) were done in the presence of MG132.
(F) Western blots of PSD-95, Mdm2, EF1a, and Tubulin from dissociated Fmr1 KO cortical neurons transfected with MEF2-VP16ERtm and either control
shRNA, EF1a shRNA, and/or Mdm2 shRNA as indicated. Treatment with vehicle or tamoxifen is also as indicated. Quantification is shown on the bottom. n = 4
cultures.
(G) Average evoked EPSC amplitude (G1) and mEPSC frequency (G2) from untransfected and control shRNA with MEF2-VP16ERtm-transfected Fmr1 KO cells.
n = 11 for both G1 and G2.
(H) Average evoked EPSC amplitude (H1) and mEPSC frequency (H2) from untransfected and EF1a shRNA with MEF2-VP16ERtm-transfected Fmr1 KO cells.
n = 9 for both H1 and H2.
(legend continued on next page)
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elimination in the somatosensory barrel cortex is deficient in
Fmr1 KO mice (Pan et al., 2010). The molecular mechanisms
that lead to elevated dendritic spine number or the deficits in
synapse elimination associated with fragile X are unknown.
Current evidence suggests that FMRP functions as a transla-
tional switch of its target mRNAs. At steady state, FMRP
suppresses translation of its mRNA targets in dendrites, and it
derepresses or stimulates their translation upon synaptic stimu-
lation dephosphorylation and/or degradation (Bassell and
Warren, 2008; Niere et al., 2012). Consistent with this model,
we observed elevated Pcdh10 translation rates in Fmr1 KO
neurons that were not stimulated by MEF2 despite induction of
Pcdh10 mRNA. Alternatively, Pcdh10 translation rates in Fmr1
KO neurons may be saturated and cannot be further increased
by elevated mRNA. We would expect that translational control
of other FMRP target mRNAs that are induced in response to
MEF2 would be similarly affected in Fmr1 KO neurons.
Although translational control of Pcdh10 is abnormal in Fmr1
KO neurons, our results suggest that this does not underlie the
deficit in MEF2-induced synapse elimination. Knocking down
EF1a restores MEF2-induced synapse elimination in Fmr1 KO
mice without affecting Pcdh10 protein levels. Therefore, one
requirement of FMRP in MEF2-induced synapse elimination is
to suppress steady-state translation of EF1a and allow appro-
priate MEF2-regulated synaptic targeting of Mdm2 and PSD-
95 ubiquitination. This highlights the importance of translational
suppression and regulation of protein concentration in dendrites
for proper synaptic plasticity. Loss-of-function mutations in the
MEF2 isoform, Mef2C, Fmr1, or Pcdh10 are all associated with
autism, with or without intellectual disability (Abrahams and
Geschwind, 2008; Morrow et al., 2008; Novara et al., 2010).
Here, we have described distinct roles for all three genes in
regulated degradation of PSD-95 and synapse elimination.
This work suggests a common deficit in activity-dependent
synapse elimination among different genetic causes of autism.
EXPERIMENTAL PROCEDURES
Organotypic Slice Culture and Dissociated Neuron Culture
Organotypic hippocampal slice cultures were made from postnatal day (P) 6–7
WT or Fmr1 KOmice bred from the congenic C57BL/6 mouse strain and trans-
fected as described (Pfeiffer et al., 2010) (Extended Experimental Procedures).
Dissociated hippocampal or cortical cultures were prepared from P0-1 WT
and Fmr1 KO mice as described (Niere et al., 2012).
Electrophysiology
Dual whole-cell patch recordings were obtained from CA1 pyramidal neurons
in slice cultures using IR-DIC and GFP fluorescence to identify nontransfected
and transfected neurons as described (Pfeiffer et al., 2010) (Extended Exper-
imental Procedures).
Synaptoneurosome Preparation
Hippocampal synaptoneurosomes were prepared as previously described
(Waung et al., 2008). For synaptoneurosomes of dissociated cultures, cells(I) Average evoked EPSC amplitude (I1) and mEPSC frequency (I2) from untr
EF1a-transfected Fmr1 KO cells (n = 13 for both I1 and I2). Error bars represent S
plots and on the right of each figure, respectively. *p < 0.05, **p < 0.01.
(J) Working model of MEF2-induced synapse elimination in WT neurons and the
See also Figure S7 and Table S1.
Cwere scraped off in buffer: 118 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO4,
2.5 mM CaCl2, 1.53 mM KH2PO4, 212.7 mM glucose, 1 mM DTT (pH 7.4),
and protease inhibitor cocktail (Calbiochem) followed by same procedures
as described (Waung et al., 2008).
Statistical Analysis
Formultiple comparisons, two-way ANOVA andBonferroni posthoc tests were
performed. Paired t tests were used for electrophysiology assays. Indepen-
dent t test was used for Figures 1D, 5B, 5F, 6C, and 7A. In all figures, error
bars represent SEM; *p < 0.05, **p < 0.01, ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and one table and can be found with this article at http://dx.doi.org/
10.1016/j.cell.2012.11.040.
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